WCLC 2025 - Posters & ePosters-P3.03.02 WEE1 as the Target for Circumvention of ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutated Lung Cancer

P3.03.02 WEE1 as the Target for Circumvention of ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutated Lung Cancer

Asset Subtitle

Seiji Yano

Meta Tag

Speaker Seiji Yano

Topic Tumor Biology – Translational Biology